218 related articles for article (PubMed ID: 23454012)
1. Memantine-sulfur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer's disease.
Sozio P; Cerasa LS; Laserra S; Cacciatore I; Cornacchia C; Di Filippo ES; Fulle S; Fontana A; Di Crescenzo A; Grilli M; Marchi M; Di Stefano A
Eur J Pharm Sci; 2013 May; 49(2):187-98. PubMed ID: 23454012
[TBL] [Abstract][Full Text] [Related]
2. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
Song MS; Rauw G; Baker GB; Kar S
Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381
[TBL] [Abstract][Full Text] [Related]
3. In vitro galantamine-memantine co-application: mechanism of beneficial action.
Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
[TBL] [Abstract][Full Text] [Related]
4. Chromone-lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities.
Jalili-Baleh L; Nadri H; Forootanfar H; Küçükkılınç TT; Ayazgök B; Sharifzadeh M; Rahimifard M; Baeeri M; Abdollahi M; Foroumadi A; Khoobi M
Daru; 2021 Jun; 29(1):23-38. PubMed ID: 33420969
[TBL] [Abstract][Full Text] [Related]
5. Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization.
Laserra S; Basit A; Sozio P; Marinelli L; Fornasari E; Cacciatore I; Ciulla M; Türkez H; Geyikoglu F; Di Stefano A
Int J Pharm; 2015 May; 485(1-2):183-91. PubMed ID: 25747452
[TBL] [Abstract][Full Text] [Related]
6. Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-β peptide in Alzheimer's disease.
Rosini M; Simoni E; Caporaso R; Basagni F; Catanzaro M; Abu IF; Fagiani F; Fusco F; Masuzzo S; Albani D; Lanni C; Mellor IR; Minarini A
Eur J Med Chem; 2019 Oct; 180():111-120. PubMed ID: 31301562
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40).
Miguel-Hidalgo JJ; Alvarez XA; Cacabelos R; Quack G
Brain Res; 2002 Dec; 958(1):210-21. PubMed ID: 12468047
[TBL] [Abstract][Full Text] [Related]
8. Anti-autophagic and anti-apoptotic effects of memantine in a SH-SY5Y cell model of Alzheimer's disease via mammalian target of rapamycin-dependent and -independent pathways.
Song G; Li Y; Lin L; Cao Y
Mol Med Rep; 2015 Nov; 12(5):7615-22. PubMed ID: 26459718
[TBL] [Abstract][Full Text] [Related]
9. Non-cholinergic strategies for treating and preventing Alzheimer's disease.
Doraiswamy PM
CNS Drugs; 2002; 16(12):811-24. PubMed ID: 12421115
[TBL] [Abstract][Full Text] [Related]
10. Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease.
Pinnen F; Sozio P; Cacciatore I; Cornacchia C; Mollica A; Iannitelli A; D'Aurizio E; Cataldi A; Zara S; Nasuti C; Di Stefano A
Arch Pharm (Weinheim); 2011 Mar; 344(3):139-48. PubMed ID: 21384412
[TBL] [Abstract][Full Text] [Related]
11. Ibuprofen and lipoic acid diamides as potential codrugs with neuroprotective activity.
Sozio P; D'Aurizio E; Iannitelli A; Cataldi A; Zara S; Cantalamessa F; Nasuti C; Di Stefano A
Arch Pharm (Weinheim); 2010 Mar; 343(3):133-42. PubMed ID: 20186865
[TBL] [Abstract][Full Text] [Related]
12. Exploiting the lipoic acid structure in the search for novel multitarget ligands against Alzheimer's disease.
Rosini M; Simoni E; Bartolini M; Tarozzi A; Matera R; Milelli A; Hrelia P; Andrisano V; Bolognesi ML; Melchiorre C
Eur J Med Chem; 2011 Nov; 46(11):5435-42. PubMed ID: 21924801
[TBL] [Abstract][Full Text] [Related]
13. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.
Lipton SA
Curr Drug Targets; 2007 May; 8(5):621-32. PubMed ID: 17504105
[TBL] [Abstract][Full Text] [Related]
14. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
Tanović A; Alfaro V
Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529
[TBL] [Abstract][Full Text] [Related]
15. Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801.
Nakamura S; Murayama N; Noshita T; Katsuragi R; Ohno T
Eur J Pharmacol; 2006 Oct; 548(1-3):115-22. PubMed ID: 16952349
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity.
Volbracht C; van Beek J; Zhu C; Blomgren K; Leist M
Eur J Neurosci; 2006 May; 23(10):2611-22. PubMed ID: 16817864
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent folic acid and memantine treatments promote synergistic or additive protection against Aβ(25-35) peptide-induced apoptosis in SH-SY5Y cells mediated by mitochondria stress-associated death signals.
Chen TF; Tang MC; Chou CH; Chiu MJ; Huang RF
Food Chem Toxicol; 2013 Dec; 62():538-47. PubMed ID: 24055771
[TBL] [Abstract][Full Text] [Related]
18. Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons.
Aracava Y; Pereira EF; Maelicke A; Albuquerque EX
J Pharmacol Exp Ther; 2005 Mar; 312(3):1195-205. PubMed ID: 15522999
[TBL] [Abstract][Full Text] [Related]
19. Novel 3-phenylcoumarin-lipoic acid conjugates as multi-functional agents for potential treatment of Alzheimer's disease.
Jalili-Baleh L; Nadri H; Forootanfar H; Samzadeh-Kermani A; Küçükkılınç TT; Ayazgok B; Rahimifard M; Baeeri M; Doostmohammadi M; Firoozpour L; Bukhari SNA; Abdollahi M; Ganjali MR; Emami S; Khoobi M; Foroumadi A
Bioorg Chem; 2018 Sep; 79():223-234. PubMed ID: 29775948
[TBL] [Abstract][Full Text] [Related]
20. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
Sonkusare SK; Kaul CL; Ramarao P
Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
